Intracameral mydriatics in phacoemulsification cataract surgery - a 6-year follow-up
2013 (English)In: Acta Ophthalmologica, ISSN 1755-375X, E-ISSN 1755-3768, Vol. 91, no 3, 243-246 p.Article in journal (Refereed) Published
Purpose: To evaluate the long-term safety of intracameral mydriatics (ICM) in phacoemulsification cataract surgery compared with conventional topical mydriatics (TM). Methods: A total of 45 patients were examined 6 years after phacoemulsification cataract surgery. The patients had previously participated in a prospective randomized double-blind study including 60 patients, operated with either ICM or TM. The follow-up included best-corrected visual acuity (BCVA), intraocular pressure (IOP), grade of posterior capsule opacification (PCO), YAG laser capsulotomy rate, pupil size, corneal thickness and endothelial morphology. Results: No differences in postoperative BCVA, IOP, pupil size, PCO or YAG rate were observed between the groups. Endothelial cell loss, endothelial morphology and corneal thickness were also equivalent. Conclusions: Intracameral mydriatics is a safe alternative to topical mydriatics in phacoemulsification cataract surgery with no long-term disadvantages at 6-year follow-up.
Place, publisher, year, edition, pages
2013. Vol. 91, no 3, 243-246 p.
cataract surgery, endothelial cell loss, Intracameral mydriatics, phenylephrine, posterior capsule opacification, pupil dilatation, topical mydriatics
IdentifiersURN: urn:nbn:se:umu:diva-71589DOI: 10.1111/j.1755-3768.2011.02378.xISI: 000317983000029OAI: oai:DiVA.org:umu-71589DiVA: diva2:625848